Researchers use Lumosity to identify early cognitive impairment in cirrhosis patients

March 5, 2014, Lumosity

March 5, 2014 – A new study from the University of Washington has found that performance on Lumosity games can distinguish between patients with cirrhosis of the liver, pre-cirrhotic patients, and healthy controls. The study used Lumosity games as psychometric tests to detect subtle cognitive impairments in patients with cirrhosis. The study is published in the March issue of the American Journal of Gastroenterology.

Studies have found that an estimated 60-80 percent of cirrhosis patients experience cognitive dysfunction, which can range from subtle neurocognitive abnormalities in those with minimal hepatic encephalopathy (MHE) to overt hepatic encephalopathy (OHE), a toxic condition that can lead to confusion, fatigue, or coma. Clinical testing can detect cognitive changes in cirrhotic patients with OHE, but currently no gold standard exists for the clinical assessment of MHE.

"Subtle cognitive impairments in cirrhosis patients are commonly undiagnosed, and are associated with poor self-reported quality of life, driving accidents, falls, or the development of OHE." said George Ioannou, M.D., M.S., Associate Professor at the University of Washington School of Medicine, Division of Gastroenterology and Staff Physician at VA Puget Sound Health Care System, and senior author on the study. "This finding is interesting because it suggests a new, easily accessible and affordable approach to identifying early cognitive impairments in patients with cirrhosis, which can potentially improve quality of life and prevent the onset of OHE."

The study administered three types of psychometric tests in cirrhotic patients without OHE (n = 31), patients with pre-cirrhotic chronic liver disease (n = 28), and normal controls (n = 16). The tests included:

  1. The Number Connection Test A (NCT-A) presents test-takers with 25 numbers arranged in an arbitrary sequence that are to be connected as quickly as possible in the correct sequence.
  2. The Inhibitory Control Test (ICT) presents a random sequence of letters among which test-takers need to discern interchanging X's and Y's and press a button when either of these two letters follows the other.
  3. Five Lumosity games administered on an iPad, including Speed Match – an adaptation of the N-back that challenges speed and information processing; Color Match – an adaptation of the Stroop task that challenges flexibility and response inhibition; Memory Matrix – a visual pattern memory task that challenges memory and spatial recall; Lost in Migration – an adaptation of the Flanker task that challenges attention and selective attention; and Chalkboard Challenge – an arithmetic comparison task that challenges problem solving and quantitative reasoning.

Unlike the NCT-A or ICT, Lumosity games were able to reliably differentiate cirrhosis patients without OHE from pre-cirrhotic patients. Specifically, the results for Color Match and Memory Matrix were found to be statistically significant in differentiating between those with cirrhosis and pre- (p = 0.009 and p = 0.04 for Color Match and Memory Matrix respectively), as well as between normal controls and those with cirrhosis (p = 0.04 and p = 0.04) when adjusted for age and educational attainment. Higher scores on these two games were also associated with a reduced likelihood of cirrhosis, suggesting the combination of Color Match and Memory Matrix may improve cirrhosis detection. Test-retest reliability, as measured by Pearson's r correlation coefficient, for each Lumosity game ranged from r = 0.75 to 0.84 compared to the NCT, where r = 0.75, suggesting repeatability of the Lumosity games.

"We created Lumosity to be an accessible tool for both consumers and researchers, and we're excited that our cognitive training program can be used in a variety of ways to study cognitive function in specific populations," said Joe Hardy, Ph.D., VP of Research & Development at Lumosity. "This study is a novel use-case of Lumosity and we welcome additional research using Lumosity to detect subtle cognitive impairments in those with of the liver and in other conditions."

Explore further: Smartphone app found to be valid tool in screening for minimal hepatic encephalopathy

More information: The American Journal of Gastroenterology 109, 316-323 (March 2014) DOI: 10.1038/ajg.2013.306

Related Stories

Smartphone app found to be valid tool in screening for minimal hepatic encephalopathy

September 18, 2013
A smartphone app can quickly screen for cognitive dysfunction often found in patients with cirrhosis, according to a new Virginia Commonwealth University study. The cognitive dysfunction, known as minimal hepatic encephalopathy ...

Glycerol phenylbutyrate reduces hepatic encephalopathy events

February 25, 2014
Phase 2 trial results published in the March issue of Hepatology, a journal of the American Association for the Study of Liver Diseases, suggests the potential for Glycerol Phenylbutyrate (GPB) to reduce hepatic encephalopathy ...

Detection and treatment for hepatic encephalopathy prevents car accidents, reduces costs

March 27, 2012
A late stage liver condition, known as minimal hepatic encephalopathy (MHE), is associated with impaired driving skills and greater risk of motor vehicle accidents. Cost analysis of management strategies for detection and ...

GI cancer resection OK with mild cirrhotic liver dysfunction

July 10, 2012
(HealthDay) -- For patients with cirrhosis, resection of gastrointestinal (GI) malignancies correlates with poor early postoperative outcomes, with severity of liver disease being the primary determinant of postoperative ...

Recommended for you

New study offers insights on genetic indicators of COPD risk

January 16, 2018
Researchers have discovered that genetic variations in the anatomy of the lungs could serve as indicators to help identify people who have low, but stable, lung function early in life, and those who are particularly at risk ...

Previous influenza virus exposures enhance susceptibility in another influenza pandemic

January 16, 2018
While past exposure to influenza A viruses often builds immunity to similar, and sometimes different, strains of the virus, Canadian researchers are calling for more attention to exceptions to that rule.

Don't hold your nose and close your mouth when you sneeze, doctors warn

January 15, 2018
Pinching your nose while clamping your mouth shut to contain a forceful sneeze isn't a good idea, warn doctors in the journal BMJ Case Reports.

New antifungal provides hope in fight against superbugs

January 12, 2018
Microscopic yeast have been wreaking havoc in hospitals around the world—creeping into catheters, ventilator tubes, and IV lines—and causing deadly invasive infection. One culprit species, Candida auris, is resistant ...

Dengue takes low and slow approach to replication

January 11, 2018
A new study reveals how dengue virus manages to reproduce itself in an infected person without triggering the body's normal defenses. Duke researchers report that dengue pulls off this hoax by co-opting a specialized structure ...

Different strains of same bacteria trigger widely varying immune responses

January 11, 2018
Genetic differences between different strains of the same pathogenic bacterial species appear to result in widely varying immune system responses, according to new research published in PLOS Pathogens.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.